FDA Inspection 846115 — Celgene Corporation
The FDA completed an inspection of Celgene Corporation on Aug 7, 2013 in Warren, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 7, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warren, NJ (United States)
Additional Details
Sponsor, Contract Research Organization